Struthers Richard Scott — SEC Form 4 filings
SEC reporting owner CIK 1746298. 19 Form 4 filings on record with FilingPulse; latest filed 2026-09-01.
Transaction summary — filings shown
Covers all 19 filings on record, filed 2024-02-14 to 2026-09-01. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 8 legs across 6 filings — 201,718 shares, $9,491,722 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 68.
- Largest priced transaction: sale of 107,448 shares @ $49.40 ($5,307,931) in Crinetics Pharmaceuticals, Inc., filed 2024-05-10.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Crinetics Pharmaceuticals, Inc. (CRNX) | President & CEO, Director | 19 | — | 8 legs · 201,718 sh · $9,491,722 | 68 |
Form 4 filings — Struthers Richard Scott
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-01 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Disposition to issuer (D): 248,043 @ $85 · Disposition to issuer (D): 1,000 @ $85 · Disposition to issuer (D): 136,805 @ $85 · Disposition to issuer (D): 106,000 @ $85 · Disposition to issuer (D): 110,000 @ $85 · Disposition to issuer (D): 100,000 @ $85 · +14 more | EDGAR |
| 2026-08-11 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Option exercise (M): 3,969 @ $25.19 · Option exercise (M): 4,422 @ $22.61 · Option exercise (M): 6,542 @ $15.29 · Option exercise (M): 4,995 @ $20.02 · Option exercise (M): 3,969 (derivative) @ $0 · Option exercise (M): 4,422 (derivative) @ $0 · +2 more | EDGAR |
| 2026-06-02 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Gift (G): 222,200 @ $0 · Gift (G): 222,200 @ $0 · Gift (G): 80,000 @ $0 · Gift (G): 222,200 @ $0 · Gift (G): 222,200 @ $0 · Gift (G): 80,000 @ $0 · +8 more | EDGAR |
| 2026-03-18 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Sale (S): 13,196 @ $37.11 · Sale (S): 8,785 @ $37.77 | EDGAR |
| 2026-02-25 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Grant/award (A): 62,000 @ $0 · Grant/award (A): 228,000 (derivative) @ $0 | EDGAR |
| 2025-12-18 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Option exercise (M): 16,342 @ $9.28 · Option exercise (M): 28,400 @ $15.29 · Option exercise (M): 16,342 (derivative) @ $0 · Option exercise (M): 28,400 (derivative) @ $0 | EDGAR |
| 2025-09-30 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Sale (S): 4,000 @ $45 | EDGAR |
| 2025-05-16 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Gift (G): 90,400 @ $0 · Gift (G): 90,400 @ $0 | EDGAR |
| 2025-04-04 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Option exercise (M): 81,270 @ $1.91 · Option exercise (M): 81,270 (derivative) @ $0 | EDGAR |
| 2025-03-21 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Sale (S): 16,463 @ $34.17 · Sale (S): 875 @ $34.83 | EDGAR |
| 2025-02-24 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Grant/award (A): 89,000 @ $0 · Grant/award (A): 313,000 (derivative) @ $0 | EDGAR |
| 2024-12-04 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Sale (S): 10,000 @ $57.57 | EDGAR |
| 2024-05-10 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Option exercise (M): 107,448 @ $9.28 · Sale (S): 107,448 @ $49.40 · Option exercise (M): 107,448 (derivative) @ $0 | EDGAR |
| 2024-04-22 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Gift (G): 350 @ $0 | EDGAR |
| 2024-04-17 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Option exercise (M): 20,000 @ $1.91 · Option exercise (M): 20,000 (derivative) @ $0 | EDGAR |
| 2024-04-08 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Option exercise (M): 40,951 @ $9.28 · Sale (S): 40,951 @ $49.17 · Option exercise (M): 40,951 (derivative) @ $0 | EDGAR |
| 2024-03-20 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Tax withholding (F): 12,687 @ $38.14 | EDGAR |
| 2024-03-06 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Grant/award (A): 65,000 @ $0 · Grant/award (A): 240,000 (derivative) @ $0 | EDGAR |
| 2024-02-14 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Gift (G): 60,000 @ $0 · Gift (G): 20,000 @ $0 · Gift (G): 20,000 @ $0 · Gift (G): 20,000 @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1746298 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →